Epilepsy Incidence Among Children in the United States
ID: 355205Type: Posted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$0 - $500K

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355205

Additional Information

https://nap.nationalacademies.org/read/13379/chapter/1
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) has announced a Notice of Funding Opportunity (NOFO) titled "Epilepsy Incidence Among Children in the United States," aimed at estimating the incidence of epilepsy among U.S. children aged 0 to 17 and identifying disparities influenced by demographic factors and social determinants of health. The initiative seeks to conduct a comprehensive study utilizing nationwide datasets to provide insights into epilepsy incidence, risk factors, and incidence disparities, thereby informing public health policies and resource allocation. With a total funding amount of $1.6 million available for a cooperative agreement over four years, the anticipated award for the first budget year is $500,000. Interested applicants, including small businesses and various organizations, must submit their applications by January 23, 2025, with a letter of intent due by December 12, 2024. For further inquiries, applicants can contact Natalie Brown at nbrown3@cdc.gov.

    Point(s) of Contact
    nbrown3@cdc.gov
    Files
    Title
    Posted
    RFA-DP-25-038_20241106.pdf
    The Centers for Disease Control and Prevention (CDC) issued a Notice of Funding Opportunity (NOFO) titled "Epilepsy Incidence Among Children in the United States" under RFA-DP-25-038. The goal is to estimate the overall incidence of epilepsy among U.S. children aged 0 to 17 and identify disparities in incidence rates influenced by demographic factors and social determinants of health. The funding of $1.6 million is available for the cooperative agreement covering a four-year period, with an anticipated single award of $500,000 for the first budget year. Eligible applicants include various organizations such as state and local governments, public and private higher education institutions, and nonprofit organizations. The application deadline is January 23, 2025, with a letter of intent due by December 12, 2024. Researchers are encouraged to leverage advanced data science techniques, including machine learning, to ascertain epilepsy cases and identify risk factors. This initiative aligns with Healthy People 2030 objectives and CDC priorities, aiming to improve health outcomes for children with epilepsy by informing public health policy and research gaps. Evaluation of applications will be based on specific scientific merit criteria, encompassing significance, innovation, approach, investigator qualifications, and the overall impact on the field.
    Similar Opportunities
    Long-term health outcomes of People Living with Spina Bifida based on the National Spina Bifida Patient Registry
    Active
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity titled "Long-term health outcomes of People Living with Spina Bifida based on the National Spina Bifida Patient Registry." This initiative aims to collect high-quality longitudinal data on individuals with spina bifida through specialized clinics and to implement a protocol for managing urinary and kidney systems in young children with myelomeningocele. The program is critical for understanding health outcomes and improving care for this population, with an estimated total funding of $2,330,000, awarding between $166,428 and $488,571 to approximately 19 recipients. Interested small businesses can reach out to Stephanie Griswold at 404-718-2623 or via email at eut6@cdc.gov for further details, with applications due by April 4, 2025, and project start anticipated in September 2025.
    Comprehensive Analysis, Surveillance, and Statistics Initiative for Diabetes in the Young (CASSIDY)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled the Comprehensive Analysis, Surveillance, and Statistics Initiative for Diabetes in the Young (CASSIDY) through cooperative agreements. This initiative aims to conduct comprehensive surveillance on the incidence and prevalence of diabetes among youth under 18 years and young adults aged 18-44 across various health systems and membership-based centers in the United States, focusing on identifying disparities and risk factors associated with diabetes. The initiative is critical for enhancing the understanding of diabetes types, complications, and demographic disparities, ultimately informing public health strategies to reduce the burden of diabetes in these populations. The total estimated funding for this program is $12.8 million, with up to six awards available, and applications are due by January 10, 2025. For further inquiries, interested applicants can contact Dr. Celeste Sanders at CSanders4@cdc.gov.
    Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships
    Active
    Centers for Disease Control - NCCDPHP
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships." This initiative aims to address significant gaps in lupus awareness and care by supporting national organizations in reducing the time to diagnosis, improving care coordination, and enhancing self-management among lupus patients. The program is particularly focused on increasing healthcare provider education and promoting effective self-management tools for individuals affected by lupus, a systemic autoimmune disease that disproportionately impacts women, especially those from minority communities. The estimated total program funding is $17.5 million, with individual awards ranging from $1.4 million to $1.8 million, and applications are due by May 2, 2025. Interested applicants can reach out to Stephanie Hinton at 678-938-9722 or via email at qxk8@cdc.gov for further information.
    Enhancing Timely Data Reporting, Quality, and Use in Early Hearing Detection and Intervention (EHDI) Surveillance
    Active
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) has announced a Notice of Funding Opportunity (NOFO) titled "Enhancing Timely Data Reporting, Quality, and Use in Early Hearing Detection and Intervention (EHDI) Surveillance." This initiative aims to support jurisdictional EHDI programs in improving data quality and utilization to ensure timely diagnosis and intervention for infants who are deaf or hard of hearing (D/HH). The program is structured into two components: Component A focuses on enhancing data quality in state EHDI Information Systems and fostering collaborations for better data integration, while Component B allows for the collection of language outcome data, emphasizing partnerships with early intervention services. The total estimated funding for this opportunity is approximately $35.2 million, with applications due by March 3, 2025. Interested applicants can reach out to Deidra Green at ehdico-op@cdc.gov for further information.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative, structured as a cooperative agreement, focuses on three key components: enhancing healthcare provider knowledge and practices regarding Chagas disease, expanding public health surveillance for soil-transmitted helminths, and addressing other significant parasitic diseases of domestic concern. With an estimated total program funding of $10 million and an award ceiling of $1 million, the CDC anticipates making approximately seven awards, with applications due by May 2, 2025. Interested applicants can reach out to Emily Dodd at 404-639-3753 or via email at iog2@cdc.gov for further information.
    Enhancing Public Health Surveillance of Bleeding Disorders
    Active
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Enhancing Public Health Surveillance of Bleeding Disorders." This initiative aims to collect and utilize surveillance data from federally supported hemophilia treatment centers to inform policies and clinical practices related to hemophilia, von Willebrand disease, and other inherited bleeding disorders, ultimately seeking to reduce health complications and improve the quality of life for affected individuals. The program is critical for understanding treatment practices, monitoring health complications, and identifying causes of death among those with bleeding disorders. The estimated total program funding is $21.5 million, with individual awards ranging from $100,000 to $4.3 million. Interested applicants can reach out to Brandi Dupervil at (404) 498-6879 or via email at inm4@cdc.gov, with applications due by May 15, 2025, and an anticipated award date of August 31, 2025.
    Public Health Strategies to Address Alzheimer's Disease and Related Dementias: The National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption Accelerator
    Active
    Centers for Disease Control - NCCDPHP
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Public Health Strategies to Address Alzheimer's Disease and Related Dementias," aimed at enhancing public health initiatives through cooperative agreements. This initiative seeks to support organizations in developing and implementing strategies that align with the National Healthy Brain Initiative Road Map, focusing on areas such as dementia risk reduction, early detection, and caregiver support. The funding opportunity is critical as Alzheimer's disease is a leading cause of death among older adults in the U.S., and the program aims to build evidence-based practices to improve brain health and support caregivers. Interested applicants can apply for one or more of the three components, with funding amounts ranging from $750,000 to $3 million, and must submit their applications by March 7, 2025. For further inquiries, contact Alisha Etheredge at BOLD@cdc.gov or call 770-488-7884.
    Advancing the Centers of Excellence in Newcomer Health
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Advancing the Centers of Excellence in Newcomer Health," aimed at enhancing health outcomes for immigrants and refugees in the United States. This cooperative agreement seeks innovative approaches to outreach and healthcare analysis for at-risk newcomer populations, focusing on areas such as health surveillance, clinical training, and the development of health orientation materials. With an estimated total program funding of $10 million and an award ceiling of $2 million, the CDC anticipates awarding two grants, with applications due by May 2, 2025. Interested applicants, specifically private institutions of higher education, can reach out to the Domestic Team at the Immigrant & Refugee Health Branch via email at IRHBdomestic@cdc.gov or by phone at 800-232-4636 for further information.
    RFA-DD-18-000
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-DD-18-000, aimed at supporting health-related initiatives through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with the program expected to award approximately 10 grants. This funding is crucial for enhancing public health efforts, although specific funding amounts have not been disclosed. Interested parties should submit their applications by October 13, 2025, and can direct inquiries to Linton C. Browning at lbrowning@cdc.gov or by phone at 770-488-2756.
    Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity aimed at increasing awareness and knowledge of Alpha-gal Syndrome (AGS) in the United States. The initiative seeks to enhance AGS surveillance, patient care, and public understanding through strategies that include public health tracking, targeted education for at-risk populations, and dissemination of knowledge among stakeholders. With an estimated total program funding of $2,250,000, the CDC anticipates awarding three grants, with individual awards ranging from $25,000 to $1,000,000. Interested applicants can reach out to Jeff Borchert at JBorchert@cdc.gov or by phone at 970-221-6494, with applications due by January 22, 2025, and awards expected to be announced by July 1, 2025.